Cargando…
Prognostic factors of recurrence of malignant pleural effusion: what is the role of neoplasia progression?
BACKGROUND: It is known that malignant pleural effusion (MPE) recurs rapidly, in a considerable number of patients. However, some patients do not have MPE recurrence. Since MPE is associated with an average survival of 4–7 months, accurate prediction of prognosis may help recognize patients at highe...
Autores principales: | Abrão, Fernando Conrado, de Abreu, Igor Renato Louro B., de Oliveira, Mariana Campello, Viana, Geisa Garcia, Pompa Filho, José Franklin Soares, Younes, Riad Naim, Negri, Elnara Marcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139099/ https://www.ncbi.nlm.nih.gov/pubmed/32274148 http://dx.doi.org/10.21037/jtd.2020.01.13 |
Ejemplares similares
-
Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion
por: Abrão, Fernando Conrado, et al.
Publicado: (2017) -
Prognostic factors and patients’ profile in treated stage I and II lung adenocarcinoma: a Hospital’s Cancer Registry-based analysis
por: Abrão, Fernando Conrado, et al.
Publicado: (2021) -
Real-Life Long-Term Cohort of Patients With Stage IIIA Non–Small-Cell Lung Cancer: Overall Survival Related to Patients' Characteristics and Multiple Treatment Models
por: Abrão, Fernando Conrado, et al.
Publicado: (2021) -
Impact of the delay to start treatment in patients with lung cancer treated in a densely populated area of Brazil
por: Abrao, Fernando Conrado, et al.
Publicado: (2017) -
Pleural Cholesterol to the Diagnosis of Exudative Effusion
por: Rufino, Rogério, et al.
Publicado: (2014)